Meet Our Executive Team
On a mission to drive positive change in the Pharmacovigilance industry.
Greg Caswill
Chairman
Greg is a chartered accountant by training. He served as the Finance Director for PPS Europe and is also Co-Founder and Executive Co-Chairman of Envision Pharma Group, a leading provider of Medical Affairs scientific and technology solutions.
Adam Sherlock
Chief Executive Officer
Adam is an experienced CEO and pharmacovigilance leader. He brings more than 35 years’ experience of critical safety service and technology solution provision to biopharma R&D, Commercial and Operations functions. Across an impressive career to date, he has held senior roles at Rephine, Arriello, Kinapse, ProductLife Group and CSC. He is known for his innovative vision, forward-thinking corporate strategy, and proactive and enthusiastic leadership.
Angela Weston
Chief Business Officer
With over 20 years of commercial and operational expertise in healthcare both within service provision and Biopharma/Medical Device, Angela drives commercial strategy, growth and ensures client satisfaction & success through collaborative management and support of her teams.
John Cogan
Chief Operating Officer
John is an industry veteran with over three decades’ experience in R&D transformation, champions operational excellence, fosters innovation, and delivers solutions that help organisations flourish in an ever-evolving life sciences landscape.
Martin Holm-Petersen
Chief Technology & Innovation Officer
Martin is an executive leader with 20 years of experience in Life Sciences, specializing in pharmacovigilance and digital transformation. He is the CEO of Insife (a Qinecsa company) and Chief Strategy Officer at Qinecsa, driving innovation with industry and regulatory partners.
Pauline Dunn
Chief of People
Pauline is a highly regarded Organizational Development and Human Resource management professional with extensive experience working at board and senior management level across multi-national organizations.
Shaun Hopgood
Chief Technology Officer
With over 30 years’ experience in the technology and pharmaceutical industries Shaun is responsible for creating a robust, agile technology foundation to support Qinecsa’s global infrastructure and market-leading product strategy.
Arthur Shih
General Counsel
Arthur is General Counsel and an Executive Leadership Team member with extensive international legal and commercial experience built over 25 years in private practice and in-house leadership roles.
Kevin John Budge
Chief Financial Officer
Kevin is an accomplished FCA with proven success in private equity-backed ventures, combining robust financial management, strategic reviews, corporate finance, and change management to elevate client value and drive growth.
Build Your Career with Qinecsa
At Qinecsa we understand the impact of the important work we do. We provide the right tools to empower our people and our passion towards drug safety makes us a unique group of talented people with common goal.
